dihydrocarminomycin

Also Known As:

carminomycinol; 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(1-hydroxyethyl)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Cardiotoxicity 01/01/1978 - "[Comparative study of the cardiotoxicity of the anthracycline antibiotics, rubomycin, carminomycin and dihydrocarminomycin, in experiments on white mice]."
2.	Neoplasms (Cancer) 04/10/1981 - "A method is given for the determination of carminomycin (CMM) and a major metabolite carminomycinol (CMMOH) in serum from cancer patients after intravenous administration of carminomycin as the free drug. "

Related Drugs and Biologics

1.	Carubicin
2.	Anthracyclines
3.	Daunorubicin (Cerubidine)
4.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Intravenous Administration